Subscribe To

Price Alert Latest News Economic Calendar News

XAIR / Beyond Air, Inc. (XAIR) Q3 2023 Earnings Call Transcript

Beyond Air, Inc. (NASDAQ:XAIR ) Q3 2023 Earnings Conference Call February 9, 2023 4:30 PM ET Company Participants Edward Barger - Head, Investor Relations Steve Lisi - Chairman and CEO Duncan Fatkin - Chief Commercial Officer Douglas Larson - Chief Financial Officer Conference Call Participants Matt Kaplan - Ladenburg Thalmann Greg Fraser - Truist Securities Yale Jen - Laidlaw & Company Suraj Kalia - Oppenheimer & Company Operator Good afternoon. And welcome everyone to the Beyond Air Financial Results Call for the Third Fiscal Quarter ended December 31, 2022. Read More

Demo Live Account See Partner Details

Content Topics

Beyond

Air

Inc

XAIR

2023

Earnings

Call

Transcript

xair

Stock

Posted: Feb 9 2023, 20:29

Author Name: Seeking Alpha

XAIR News

By GlobeNewsWire
October 4, 2023

Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GARDEN CITY, N.Y. and HAMILTON, Bermuda, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that i

By Seeking Alpha
August 10, 2023

Beyond Air, Inc. (XAIR) Q1 2024 Earnings Call Transcript

Beyond Air, Inc. (NASDAQ:XAIR ) Q1 2024 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Edward Barger - Head of Investor Rela

By Zacks Investment Research
August 10, 2023

Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates

Beyond Air, Inc. (XAIR) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to los

By Seeking Alpha
June 26, 2023

Beyond Air: Dilution Remains A Concern

Today, we take a look at an interesting small-cap medical device concern called Beyond Air, Inc. The company is just rolling out its first approved pr

By Seeking Alpha
June 22, 2023

Beyond Air, Inc. (XAIR) Q4 2023 Earnings Call Transcript

Beyond Air, Inc. (NASDAQ:XAIR ) Q4 2023 Earnings Conference Call June 22, 2023 4:30 PM ET Company Participants Edward Barger - Head of Investor Relati

By Zacks Investment Research
June 22, 2023

Beyond Air, Inc. (XAIR) Reports Q4 Loss, Lags Revenue Estimates

Beyond Air, Inc. (XAIR) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to los

By GlobeNewsWire
May 16, 2023

Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and Webcast

GARDEN CITY, N.Y., May 16, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial stage medical device and biopharmaceutical company f

By GuruFocus
April 18, 2023

5 Stocks Insiders Have Built Positions in Over the Past 3 Months

According to the Insider Cluster Buys Screen, a Premium feature of GuruFocus, five stocks that have high number of unique insider buys over the past t

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.